HAROLD SHINE to Rats
This is a "connection" page, showing publications HAROLD SHINE has written about Rats.
Connection Strength
0.608
-
Unilateral pyramidotomy of the corticospinal tract in rats for assessment of neuroplasticity-inducing therapies. J Vis Exp. 2014 Dec 15; (94).
Score: 0.075
-
Neuroimmune processes associated with Wallerian degeneration support neurotrophin-3-induced axonal sprouting in the injured spinal cord. J Neurosci Res. 2013 Oct; 91(10):1280-91.
Score: 0.068
-
Immune activation is required for NT-3-induced axonal plasticity in chronic spinal cord injury. Exp Neurol. 2008 Feb; 209(2):497-509.
Score: 0.046
-
Expression of neurotrophin-3 promotes axonal plasticity in the acute but not chronic injured spinal cord. J Neurotrauma. 2006 Aug; 23(8):1254-60.
Score: 0.042
-
Semi-automated quantification of axonal densities in labeled CNS tissue. J Neurosci Methods. 2006 Sep 15; 155(2):172-9.
Score: 0.041
-
In situ expression of brain-derived neurotrophic factor or neurotrophin-3 promotes sprouting of cortical serotonergic axons following a neurotoxic lesion. J Neurosci Res. 2005 Nov 01; 82(3):404-12.
Score: 0.040
-
Neurotrophic factors expressed in both cortex and spinal cord induce axonal plasticity after spinal cord injury. J Neurosci Res. 2003 Oct 15; 74(2):221-6.
Score: 0.035
-
Neurotrophin-3 expressed in situ induces axonal plasticity in the adult injured spinal cord. J Neurosci. 2003 Feb 15; 23(4):1424-31.
Score: 0.033
-
Stroke Recovery in Rats after 24-Hour-Delayed Intramuscular Neurotrophin-3 Infusion. Ann Neurol. 2019 01; 85(1):32-46.
Score: 0.025
-
Permanent rescue of lesioned neonatal motoneurons and enhanced axonal regeneration by adenovirus-mediated expression of glial cell-line-derived neurotrophic factor. J Neurosci Res. 1998 Dec 15; 54(6):766-77.
Score: 0.025
-
Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor. Exp Neurol. 1998 Sep; 153(1):102-12.
Score: 0.024
-
Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population. J Neurosci. 1997 Sep 01; 17(17):6504-11.
Score: 0.023
-
Delayed intramuscular human neurotrophin-3 improves recovery in adult and elderly rats after stroke. Brain. 2016 Jan; 139(Pt 1):259-75.
Score: 0.020
-
Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain. Hum Gene Ther. 1995 Oct; 6(10):1317-22.
Score: 0.020
-
Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome. Brain Res. 1995 Sep 11; 691(1-2):76-82.
Score: 0.020
-
Adenovirus-mediated gene therapy of experimental gliomas. J Neurosci Res. 1994 Nov 01; 39(4):506-11.
Score: 0.019
-
Temporal and spatial expression of ciliary neurotrophic factor after peripheral nerve injury. Exp Neurol. 1993 Jun; 121(2):239-47.
Score: 0.017
-
Immunofluorescent labeling of tight junctions in the rat brain and spinal cord. Int J Dev Neurosci. 1992 Oct; 10(5):387-92.
Score: 0.016
-
Improvement of spatial learning and memory after adenovirus-mediated transfer of the nerve growth factor gene to aged rat brain. Hum Gene Ther. 2002 Dec 10; 13(18):2173-84.
Score: 0.008
-
Effect of selective ablation of proliferating mammary epithelial cells on MNU induced rat mammary tumorigenesis. Breast Cancer Res Treat. 2002 May; 73(1):75-83.
Score: 0.008
-
Peripheral nerve injury down-regulates CNTF expression in adult rat sciatic nerves. J Neurosci Res. 1992 Jan; 31(1):188-92.
Score: 0.004